Type 2 diabetes target the cardiorenal system

This CPD-accredited report highlights all the new evidence and the best therapies available while also addressing the primary concern of HbA1c

You will learn:
The risk factors that lead to cardiac and renal dysfunction
The usefulness of bio-profiling and precision medicine in the management of the individual with diabetes
The evidence for SGLT-2 inhibitors in the treatment of cardiorenal syndrome.

To access this module, please register or login: